Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain

被引：46
|
作者：
Bedaiwy, Mohamed A.
Casper, Robert F. [1 ]
机构：
[1] Univ Toronto, Div Reprod Sci, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada
[2] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
来源：
FERTILITY AND STERILITY | 2006年 / 86卷 / 01期
关键词：
D O I：
10.1016/j.fertnstert.2005.12.030
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
This pilot study examined the effect of a low-dose E and pulsed progestogen hormone therapy (HT) regimen for add-back during long-term GnRH-agonist therapy on bone mineral density (BMD) in five patients with stage IV endometriosis. Bone mineral density was stable after initiation of HT for the entire follow-up period (up to 10 years). One patient stopped her treatment on two occasions to conceive and was successful each time with delivery of a normal baby. No patient had return of pelvic pain after HT add-back.
引用
收藏
页码：220 / 222
页数：3
相关论文
共 50 条
  • [1] Leuprolide acetate and hormonal add-back in stage IV endometriosis patients with chronic pelvic pain: A 10-year follow up.
    Bedaiwy, MA
    Casper, RF
    FERTILITY AND STERILITY, 2005, 84 : S199 - S199
  • [2] Leuprolide acetate depot and hormonal add-back in endometriosis: A 12-month study
    Marik, JJ
    OBSTETRICS AND GYNECOLOGY, 1998, 91 (05): : 793 - 793
  • [3] Leuprolide acetate depot and hormonal add-back in endometriosis: A 12-month study
    Hornstein, MD
    Surrey, ES
    Weisberg, GW
    Casino, LA
    OBSTETRICS AND GYNECOLOGY, 1998, 91 (01): : 16 - 24
  • [4] Add-back therapy in the treatment of endometriosis-associated pain
    Zupi, E
    Marconi, D
    Sbracia, M
    Zullo, F
    De Vivo, B
    Exacustos, C
    Sorrenti, G
    FERTILITY AND STERILITY, 2004, 82 (05) : 1303 - 1308
  • [5] Add-back therapy in the treatment of endometriosis associated pain.
    Zupi, E
    Sbracia, M
    Marconi, D
    Zullo, F
    Sorrenti, G
    FERTILITY AND STERILITY, 2005, 84 : S189 - S189
  • [6] Immediate and delayed add-back hormonal replacement therapy during ultra long GnRH agonist treatment of chronic cyclical pelvic pain
    Al-Azemi, M.
    Jones, G.
    Sirkeci, F.
    Walters, S.
    Houdmont, M.
    Ledger, W.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2009, 116 (12) : 1646 - 1656
  • [7] Dienogest Versus Leuprolide Acetate for Recurrent Pelvic Pain Following Laparoscopic Treatment of Endometriosis
    Abdou A.M.
    Ammar I.M.M.
    Alnemr A.A.A.
    Abdelrhman A.A.
    The Journal of Obstetrics and Gynecology of India, 2018, 68 (4) : 306 - 313
  • [8] DEPOT LEUPROLIDE ACETATE WITH ESTROGEN AND PROGESTIN ADD-BACK FOR LONG-TERM TREATMENT OF PREMENSTRUAL-SYNDROME
    MEZROW, G
    LOBO, R
    SHOUPE, D
    LEUNG, B
    SPICER, D
    PIKE, M
    FERTILITY AND STERILITY, 1994, 62 (05) : 932 - 937
  • [9] The Hormonal Profile of Norethindrone Acetate: Rationale for Add-Back Therapy With Gonadotropin-Releasing Hormone Agonists in Women With Endometriosis
    Chwalisz, Kristof
    Surrey, Eric
    Stanczyk, Frank Z.
    REPRODUCTIVE SCIENCES, 2012, 19 (06) : 563 - 571
  • [10] The Hormonal Profile of Norethindrone Acetate: Rationale for Add-Back Therapy With Gonadotropin-Releasing Hormone Agonists in Women With Endometriosis
    Kristof Chwalisz
    Eric Surrey
    Frank Z. Stanczyk
    Reproductive Sciences, 2012, 19 : 563 - 571
12345